β-Amyloid and the pathogenesis of alzheimer's disease

New England Journal of Medicine

Volumn 325, Issue 26, 1991, Pages 1849-1857

  Yankner, Bruce A ^a,b   Mesulam, M Marsel ^a   Flier, Jeffrey S ^c   Underhill, Lisa H ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; BRAIN DERIVED GROWTH FACTOR; CHOLINESTERASE INHIBITOR; SERINE PROTEINASE INHIBITOR; TACHYKININ; TAU PROTEIN;

ACETYLCHOLINE BRAIN LEVEL; AGED; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 21; GENE MUTATION; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MOUSE; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENILE DEMENTIA; SENILE PLAQUE; ANIMAL; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMAL; HUMAN; NEUROFIBRILLARY TANGLES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026432318     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199112263252605     Document Type: Review

References (130)

1. Tomlinson B.E., Blessed G., Roth M. Observations on the brains of demented old people. J Neurol Sci 1970; 11:205-42
2. Smith J.S., Kiloh L.G. The investigation of dementia: results in 200 consecutive admissions. Lancet 1981; 1:824-7
3. Katzman R. Alzheimer#x0027;s disease. N Engl J Med 1986; 314:964-73
4. Schoenberg B.S., Kokmen E., Okazaki H. Alzheimer#x0027;s disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987; 22:724-9
5. Pfeffer R.I., Afifi A.A., Chance J.M. Prevalence of Alzheimer#x0027;s disease in a retirement community. Am J Epidemiol 1987; 125:420-36
6. Evans D.A., Funkenstein H.H., Albert M.S., et al. Prevalence of Alzheimer#x0027;s disease in a community population of older persons higher than previously reported. JAMA 1989; 262:2551-6
7. Mesulam M.M. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11:592-8
8. Pogacar S., Williams R.S. Alzheimer#x0027;s disease presenting as slowly progressive aphasia. R I Med J 1984; 67:181-5
9. Crystal H.A., Horoupian D.S., Katzman R., Jotkowitz S. Biopsy-proved Alzheimer#x0027;s disease presenting as a right parietal lobe syndrome. Ann Neurol 1982; 12:186-8
10. Faden A.I., Townsend J.J. Myoclonus in Alzheimer disease: a confusing sign. Arch Neurol 1976; 33:278-80
11. Heston L.L., Lowther D.L.W., Leventhal C.M. Alzheimer#x0027;s disease: a family study. Arch Neurol 1966; 15:225-33
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer#x0027;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer#x0027;s disease. Neurology 1984; 34:939-44
13. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatrie (Berlin) 1907; 64:146-8
14. Roth M., Tomlinson B.E., Blessed G. Correlation between scores for dementia and counts of “senile plaques” in cerebral gray matter of elderly subjects. Nature 1966; 209:109-10
15. Blessed G., Tomlinson B.E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811
16. Khachaturian Z.S. Diagnosis of Alzheimer#x0027;s disease. Arch Neurol 1985; 42:1097-105
17. Crystal H., Dickson D., Fuld P., et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer#x0027;s disease. Neurology 1988; 38:1682-7
18. Dayan A.D. Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in senile dementia. Acta Neuropathol (Berl) 1970; 16:85-94
19. Dayan. Quantitative histological studies on the aged human brain. II. Senile plaques and neurofibrillary tangles in normal patients (with an appendix on their occurrence in carcinoma). Acta Neuropathol (Berl) 1970; 16:95-102
20. Wilcock G.K., Esiri M.M. Plaques, tangles and dementia: a quantitative study. J Neurol Sci 1982; 56:343-56
21. Barcikowska M., Wisniewski H.M., Bancher C., Grundke-Iqbal I. About the presence of paired helical filaments in dystrophic neuntes participating in plaque formation. Acta Neuropathol (Berl) 1989; 78:225-31
22. Kowall N.W., Kosik K.S. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer#x0027;s disease. Ann Neurol 1987; 22:639-43
23. Braak H., Braak E., Grundke-lqbal 1, Iqbal K. Occurrence of neuropil threads in the senile brain and in Alzheimer#x0027;s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986; 65:351-5
24. Braak H., Braak E. Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol 1988; 14:39-44
25. McKee AC, Kosik K.S., Kowall N.K. Neuritic pathology and dementia in Alzheimer#x0027;s disease. Ann Neurol 1991; 30:156-65
26. Terry R.D., Peck A., DeTeresa R., Schechter R., Horoupian D.S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10:184-92
27. Terry R., Katzman R. Senile dementia of the Alzheimer type: defining a disease. In: Katzman R, Terry R, eds. The neurology of aging. Vol. 22 of Contemporary neurology series. Philadelphia: F.A. Davis, 1983: 51-84
28. Hamos J.E., DeGennaro L.J., Drachman D.A. Synaptic loss in Alzheimer#x0027;s disease and other dementias. Neurology 1989; 39:355-61
29. Masliah E., Terry R.D., DeTeresa R.M., Hansen L.A. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 1989; 103:234-9
30. Masliah E., Terry R.D., Alford M., DeTeresa R., Hansen L.A. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer#x0027;s disease. Am J Pathol 1991; 138:235-46
31. Ishii T. Distribution of Alzheimer#x0027;s neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol (Berl) 1966; 6:181-7
32. Tomlinson B.E., Irving D., Blessed G. Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 1981; 49:419-28
33. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer#x0027;s disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215:1237-9
34. Mann D.M., Yates P.O., Marcyniuk B. A comparison of changes in the nucleus basalis and locus coeruleus in Alzheimer#x0027;s disease. J Neurol Neurosurg Psychiatry 1984; 47:201-3
35. Mesulam M.-M. Alzheimer plaques and cortical cholinergic innervation. Neuroscience 1986; 17:275-6
36. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer#x0027;s disease and Alzheimer senile dementia. Nature 1980; 288:279-80
37. Rossor M.N., Emson P.C., Mountjoy C.Q., Roth M., Iversen L.L. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 1980; 20:373-7
38. Beal M.F., Mazurek M.F., Tran V.T., Chattha G., Bird E.D., Martin J.B. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer#x0027;s disease. Science 1985; 229:289-91
39. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer#x0027;s disease. Lancet 1976; 2:1403
40. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10:122-6
41. Saper C.B., German D.C., White C.L. III. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer#x0027;s type: possible role in cell loss. Neurology 1985; 35:1089-95
42. Geula C., Mesulam M.-M. Cortical cholinergic fibers in aging and Alzheimer#x0027;s disease: a morphometric study. Neuroscience 1989; 33:46981
43. Drachman D.A., Leavitt J. Human memory and the cholinergic system: a relationship to aging? Arch Neurol 1974; 30:113-21
44. Bartus R.T., Dean R.L. III, Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408-14
45. Kemper T.L. Organization of the neuropathology of the amygdala in Alzheimer#x0027;s disease. In: Katzman R, ed. Biological aspects of Alzheimer#x0027;s disease. Banbury report 15. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1983: 31-6
46. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer#x0027;s disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225:1168-70
47. Hyman B.T., Van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer#x0027;s disease: an anatomic study. Neurology 1990; 40:172130
48. Kidd M. Paired helical filaments in electron microscopy of Alzheimer#x0027;s disease. Nature 1963; 197:192-3
49. Terry R.D. The fine structure of neurofibrillary tangles in Alzheimer#x0027;s disease. J Neuropathol Exp Neurol 1963; 22:629-42
50. Kosik K.S., Joachim C.L., Selkoe D.J. Microtubule-associated protein, τ (tau), is a major antigenic component of paired helical filaments in Alzheimer#x0027;s disease. Proc Natl Acad Sci U S A 1986; 83:4044-8
51. Nukina N., Ihara Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem (Tokyo) 1986; 99:1541-4
52. Kosik K.S., Orecchio L.D., Binder L., Trojanowski J.Q., Lee V.M.-Y., Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988; 1:817-25
53. Grundke-Iqbal I., Iqbal K., Quinlan M., et al. Microtubule-associated protein tau: a component of Alzheimer paired helical filaments. J Biol Chem 1986; 261:6084-9
54. Wischik C.M., Novak M., Thogersen H.C., et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 1988; 85:4506-10
55. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification of the microtubule-associated protein tau. Proc Natl Acad Sci U S A 1988; 85:4051-5
56. Kondo J., Honda T., Mori H., et al. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1988; 1:827-34
57. Grundke-Iqbal I., Iqbal K., Tung Y.-C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986; 83:4913-7
58. Wolozin B.L., Pruchnicki A., Dickson D.W., Davies P. A neuronal antigen in the brains of Alzheimer patients. Science 1986; 232:648-50
59. Wolozin B., Scicutella A., Davies P. Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 1988; 85:6202-6
60. Hyman B.T., Van Hoesen G.W., Wolozin B.L., Davies P., Kromer L.T., Damasio A.R. Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann Neurol 1988; 23:371-9
61. Ueda K., Masliah E., Saitoh T., Bakalis S.L., Scoble H., Kosik K.S. Alz-50 recognizes a phosphorylated epitope of tau protein. J Neurosci 1990; 10: 3295-304
62. Lee V.M.-Y., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991; 251:675-8
63. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer#x0027;s disease. Science 1987; 235:1641-4
64. Perry G., Friedman R., Shaw G., Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A 1987; 84:3033-6
65. Abraham C.R., Selkoe D.J., Potter H. Immunochemical identification of the serine protease inhibitor, α-antichymotrypsin in the brain amyloid deposits of Alzheimer#x0027;s disease. Cell 1988; 52:487-501
66. Snow A.D., Mar H., Nochlin D., Kimata K., et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer#x0027;s disease. Am J Pathol 1988; 133:456-63
67. Rosenblatt D.E., Geula C., Mesulam M.M. Protease nexin I immunostaining in Alzheimer#x0027;s disease. Ann Neurol 1989; 26:628-34
68. Mesulam M.-M., Geula C., Moran M.A. Anatomy of cholinesterase inhibition in Alzheimer#x0027;s disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann Neurol 1987; 22:683-91
69. Glenner G.G., Wong C.W. Alzheimer#x0027;s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120:885-90
70. Masters C.L., Multhaup G., Simms G., Pottgiesser J., Martins R.N., Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer#x0027;s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 1985; 4:2757-63
71. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 1985; 82:4245-9
72. Kang J., Lemaire H.-G., Unterbeck A., et al. The precursor of Alzheimer#x0027;s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325:733-6
73. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer#x0027;s disease amyloid protein shows protease inhibitory activity. Nature 1988; 331:530-2
74. Ponte P., Gonzalez-DeWhitt P., Schilling J., et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988; 331:525-7
75. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L.T., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer#x0027;s disease. Nature 1988; 331:528-30
76. Oltersdorf T., Fritz L.C., Schenk D.B., et al. The secreted form of Alzheimer#x0027;s amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 1989; 341:144-7
77. Van Nostrand W.E., Schmaier A.H., Farrow J.S., Cunningham D.D. Protease nexin-H (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 1990; 248:745-8
78. Weidemann A., König G., Bunke D., et al. Identification, biogenesis, and localization of precursors of Alzheimer#x0027;s disease A4 amyloid protein. Cell 1989; 57:115-26
79. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that β-amyloid protein in Alzheimer#x0027;s disease is not derived by normal processing. Science 1990; 248:492-5
80. Esch F.S., Keim P.S., Beattie E.C., et al. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 1990; 248:1122-4
81. Abraham C.R., Driscoll J., Potter H., Van Nostrand W.E., Tempst P. A calcium-activated protease from Alzheimer#x0027;s disease brain cleaves at the N-terminus of the amyloid β-protein. Biochem Biophys Res Commun 1991; 174:790-6
82. Nelson R.B., Siman R. Clipsin, a chymotrypsin-like protease in rat brain which is irreversibly inhibited by α-1-antichymotrypsin. J Biol Chem 1990; 265:3836-43
83. Cataldo A.M., Nixon R.A. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 1990; 87:3861-5
84. Selkoe D.J., Podlisny M.B., Joachim C., et al. β-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A 1988; 85:7341-5
85. Koo E.H., Sisodia S.S., Archer D.A., et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A 1990; 87:1561-5
86. Joachim C.L., Mori H., Selkoe D.J. Amyloid β-protein deposition in tissues other than brain in Alzheimer#x0027;s disease. Nature 1989; 341:226-30
87. Smith R.P., Higuchi D.A., Broze G.J. Jr. Platelet coagulation factor Xlainhibitor, a form of Alzheimer amyloid precursor protein. Science 1990; 248:1126-8
88. Tagliavini F., Giaccone G., Frangione B., Bugiani O. Preamyloid deposits in the cerebral cortex of patients with Alzheimer#x0027;s disease and nondemented individuals. Neurosci Lett 1988; 93:191-6
89. Giaccone G., Tagliavini F., Linoli G., et al. Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 1989; 97:232-8
90. Mann D.M.A. Cerebral amyloidosis, aging and Alzheimer#x0027;s disease: a contribution from studies on Down#x0027;s syndrome. Neurobiol Aging 1989; 10:397-9
91. Mann D.M.A., Esiri M.M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down#x0027;s syndrome. J Neurol Sei 1989; 89:169-79
92. Davies L., Wolska B., Hilbich C., et al. A4 amyloid protein deposition and the diagnosis of Alzheimer#x0027;s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 1988; 38:1688-93
93. Rumble B., Retallack R., Hilbich C., et al. Amyloid A4 protein and its precursor in Down#x0027;s syndrome and Alzheimer#x0027;s disease. N Engl J Med 1989; 320:1446-52
94. Joachim C.L., Morris J.H., Selkoe D.J. Diffuse amyloid plaques occur commonly in the cerebellum in Alzheimer#x0027;s disease. Am J Pathol 1989; 135: 309-19
95. Terry R.D., Wisniewski H.M. Ultrastructure of senile dementia and of experimental analogs. In Gatz CM, ed. Aging and the brain. Vol. 3 of Advances in behavioral biology. New York: Plenum Press, 1972: 89-116
96. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 1990; 250:279-82
97. Yankner B.A., Caceres A., Duffy L.K. Nerve growth factor potentiates the neurotoxicity of β amyloid. Proc Natl Acad Sci U S A 1990; 87:9020-3
98. Roher A.E., Ball M.J., Bhave S.V., Wakade A.R. β-Amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem Biophys Res Commun 1991; 174:572-9
99. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer#x0027;s disease. Science 1989; 245:417-20
100. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yankner B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci U S A 1991; 88:7247-51
101. Whitson J.S., Selkoe D.J., Cotman C.W. Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 1989; 243:1488-90
102. Joslin G., Krause J.E., Hershey A.D., Adams S.P., Fallon R.J., Perlmutter D.H. Amyloid-β peptide, substance P. and bombesin bind to the serpin-enzyme complex receptor. J Biol Chem 1991; 266:21897-902
103. Joslin G., Fallón R.J., Bullock J., Adams S.P., Perlmutter D.H. The SEC receptor region recognizes a pentapeptide neodomain of α1-antitrypsinprotease complexes. J Biol Chem 1991; 266:11282-8
104. Price D.L. New perspectives on-Alzheimer#x0027;s disease. Ann Rev Neurosci 1986; 9:489-512
105. Quon D., Wang Y., Catalano R., Scardina J.M., Murakami K., Cordell B. Formation of β amyloid protein deposits in brains of transgenic mice. Nature 1991; 352:239-41
106. Wirak D.O., Bayney R., Ramabhadran T.V., et al. Deposits of amyloid β protein in the central nervous system of transgenic mice. Science 1991; 253:323-5
107. St George-Hyslop P.H., Tanzi R.E., Polinsky R.J., et al. The genetic defect causing familial Alzheimer#x0027;s disease maps on chromosome 21. Science 1987; 235:885-90
108. Lai F., Williams R.S. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989; 46:849-53
109. Van Broeckhoven C., Genthe A.M., Vandenberghe A., et al. Failure of familial Alzheimer#x0027;s disease to segregate with the A4-amyloid gene in several European families. Nature 1987; 329:153-5
110. Tanzi R.E., St George-Hyslop P.H., Haines J.L., et al. The genetic defect in familial Alzheimer#x0027;s disease is not tightly linked to the amyloid β-protein gene. Nature 1987; 329:156-7
111. Schellenberg G.D., Bird T.D., Wijsman E.M., et al. Absence of linkage of chromosome 21q21 markers to familial Alzheimer#x0027;s disease. Science 1988; 241:1507-10
112. St George-Hyslop P.H., Haines J.L., Farrer L.A., et al. Genetic linkage studies suggest that Alzheimer#x0027;s disease is not a single homogeneous disorder. Nature 1990; 347:194-7
113. Goate A., Chartier-Harlin M.-C., Mullan M., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer#x0027;s disease. Nature 1991; 349:704-6
114. Naruse S., lgarashi S., Kobayashi H., et al. Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer#x0027;s disease. Lancet 1991; 337:978-9
115. Alzheimer#x0027;s Disease Research Group. Molecular classification of Alzheimer#x0027;s disease. Lancet 1991; 337:1342-3
116. Gabuzda D.H., Busciglio J., Yankner B.A. The familial Alzheimer#x0027;s disease mutation does not produce gross alterations in APP synthesis or processing. In: Society for Neuroscience abstracts. Vol. 17. Part 2. 21st annual meeting, New Orleans, Nov. 10–15, 1991. Washington, D.C.: Society for Neuroscience, 1991: 1104. abstract
117. Benson M.D. Familial amyloidotic poly neuropathy. Trends Neurosci 1989; 12:88-92
118. Levy E., Carman M.D., Fernandez-Madrid I.J., et al. Mutation of the Alzheimer#x0027;s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248:1124-6
119. van Duinen S.G., Castano E.M., Prelli F., Bots G., Luyendijk W., Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci U S A 1987; 84: 5991-4
120. Cohen D.H., Feiner H., Jensson O., Frangione B. Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCWHA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med 1983; 158:623-8
121. Hsiao K.K., Baker H.F., Crow T.J., et al. Linkage of a prion protein missense variant to Gerstmann-Straüssler syndrome. Nature 1989; 338:342-5
122. Hsiao K.K., Scott M., Foster D., et al. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990; 250:1587-90
123. Thai L.J., Fuld P.A., Masur D.M., Sharpless N.S. Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann Neurol 1983; 13:491-6
124. Davis K.L., Mohs R.C. Cholinergic drugs in Alzheimer#x0027;s disease. N Engl J Med 1986; 315:1286-7
125. Hefti F., Hartikka J., Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 1989; 10:515-33
126. Yankner B.A., Kowall N.M., Chen M. Nerve growth factor is increased in Alzheimer#x0027;s disease. Neurology 1991; 41:Suppl 1:270. abstract
127. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1:549-53
128. Maisonpierre P., Belluscio L., Squinto S., et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990; 247:1446-51
129. Phillips H.S., Hains J.M., Laramee G.R., Rosenthal A., Winslow J.W. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 1990; 250:290-4
130. Barrow C.J., Zagorski M.G. Solution structure of β peptide and its constituent fragments: relation to amyloid deposition. Science 1991; 253:179-82